Supplementary Data from Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer

Autor:	Silvana Mouron, Francisca Mulero, Eduardo Caleiras, Diego Malón, Juan Guerra, Javier Cortés, Antonio Lopez-Alonso, María Gion, Joel Salla Fortuny, Ariadna Gasol Cudos, Manuel Muñoz, Juan V. Apala, Luis Manso, Alfonso Cortés-Salgado, Serafín Morales, Miguel Quintela-Fandino
Rok vydání:	2023
Popis:	Supplementary material
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::542a66c4c343909e26d1145640c2e8e5 https://doi.org/10.1158/1078-0432.22475895.v1 Zobrazit plný text záznamu